准分子激光冠状动脉成形术在慢性完全闭塞性病变中的应用

发布时间：2018-04-02 20:14

本文选题：冠状动脉疾病　切入点：血管成形术　出处：《中国循环杂志》2017年03期

【摘要】：目的:观察准分子激光冠状动脉成形术(ELCA)在冠状动脉慢性完全性闭塞(CTO)病变中应用的安全性和有效性。方法:总结自2015-01至2016-11在阜外医院冠心病中心应用ELCA治疗的3例CTO病变患者,导引钢丝在对侧冠状动脉造影指引下通过闭塞段病变,应用ELCA治疗后进行药物洗脱支架置入。观察手术成功率及并发症,并随访主要心脏不良事件(MACE)发生情况。结果:3例患者ELCA器械操作全部成功、介入治疗全部成功。术中无1例发生血管夹层、穿孔、慢血流及血栓形成,随访期间无1例发生心绞痛、心肌梗死、靶病变再次血运重建及死亡。结论:应用ELCA联合药物洗脱支架治疗CTO是安全有效的。
[Abstract]:Objective: to observe the safety and efficacy of ELCA in the treatment of chronic complete occlusion of coronary artery (CTO).Methods: from January 2015 to November 2016-11, 3 patients with ELCA were treated with ELCA in the coronary heart disease center of Fuwei Hospital. Under the guidance of contralateral coronary arteriography, three patients with CTO lesions were treated with Drug-eluting Stent after ELCA treatment and guided by contralateral coronary arteriography.The successful rate of operation and complications were observed, and the occurrence of major adverse cardiac events (MACEE) was followed up.Results the operation of ELCA instruments and interventional therapy were all successful in 3 cases.No dissection, perforation, slow blood flow and thrombosis occurred during the operation, and no angina pectoris, myocardial infarction, re-revascularization and death of the target lesions occurred during the follow-up period.Conclusion: ELCA combined with drug-eluting stent is safe and effective in the treatment of CTO.
【作者单位】：中国医学科学院北京协和医学院国家心血管病中心阜外医院冠心病诊治中心;
【分类号】：R543.3

【相似文献】